Testing effectiveness (Phase 2)Study completedNCT00510640What this trial is testingThyroid Cancer and SunitinibWho this might be right forCancerThyroid Carcinoma University Hospital, Bordeaux 71
Not applicableUnknownNCT05819593What this trial is testingEvaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study ExperiencesWho this might be right forAnaplastic Thyroid Cancer Power Life Sciences Inc. 500
Not applicableEnded earlyNCT00416949What this trial is testingIodine I 131 in Treating Patients With Thyroid CancerWho this might be right forHead and Neck Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT00625846What this trial is testingPazopanib Hydrochloride in Treating Patients With Advanced Thyroid CancerWho this might be right forRecurrent Thyroid Gland CarcinomaStage III Differentiated Thyroid Gland Carcinoma AJCC v7Stage III Thyroid Gland Medullary Carcinoma AJCC v7+10 more National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06856278What this trial is testingClinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATCWho this might be right forAnaplastic Throid Carcinoma Zhejiang Provincial People's Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT03449108What this trial is testingLN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue SarcomasWho this might be right forBone SarcomaDedifferentiated ChondrosarcomaGiant Cell Tumor of Bone+13 more M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00126568What this trial is testingSorafenib in Treating Patients With Advanced Anaplastic Thyroid CancerWho this might be right forAnaplastic Thyroid CancerRecurrent Thyroid Cancer National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT02244463What this trial is testingA Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid CancerWho this might be right forAnaplastic Thyroid CancerThyroid CancerDifferentiated Thyroid Cancer Dana-Farber Cancer Institute 46
Early research (Phase 1)Active Not RecruitingNCT05557045What this trial is testingJZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Who this might be right forAdvanced CancerMetastatic CancerSolid Tumor+4 more Jazz Pharmaceuticals 98
Testing effectiveness (Phase 2)Study completedNCT04552769What this trial is testingAbemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid CancerWho this might be right forThyroid CancerAnaplastic Thyroid CancerUndifferentiated Thyroid Cancer Stanford University 9
Early research (Phase 1)Temporarily pausedNCT04418167What this trial is testingJSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway MutationsWho this might be right forSolid Tumors JS InnoPharm, LLC 71
Testing effectiveness (Phase 2)UnknownNCT02041260What this trial is testingA Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line SettingWho this might be right forDifferentiated Thyroid Cancer (DTC)Poorly Differentiated Thyroid Cancer Thomas Jefferson University 43
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT02657369What this trial is testingTrial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)Who this might be right forThyroid Carcinoma, Anaplastic Eisai Inc. 34
Testing effectiveness (Phase 2)Study completedNCT00095836What this trial is testingGefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine TherapyWho this might be right forHead and Neck Cancer Massachusetts General Hospital 27
Early research (Phase 1)Study completedNCT00005647What this trial is testingSU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and NeckWho this might be right forHead and Neck Cancer Case Comprehensive Cancer Center 12
Early research (Phase 1)Study completedNCT00098943What this trial is testingNGR-TNF in Treating Patients With Advanced Solid TumorsWho this might be right forColorectal CancerHead and Neck CancerKidney Cancer+1 more European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)Looking for participantsNCT06374602What this trial is testingEfficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid CancerWho this might be right forAnaplastic Thyroid Cancer Saint Petersburg State University, Russia 20
Testing effectiveness (Phase 2)Study completedNCT03211117What this trial is testingPembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid CancerWho this might be right forThyroid Gland Undifferentiated (Anaplastic) Carcinoma Mayo Clinic 3